Remodelling delivery of mAbs in rheumatoid arthritis

Tocilizumab, a monoclonal antibody targeted at the interleukin-6 receptor, is now available as a subcutaneous formulation for the management of moderate to severe rheumatoid arthritis

Source: Pharmacy Europe - February 16, 2015 Category: Drugs & Pharmacology Authors: ebercott Tags: Rheumatology Featured Articles Source Type: news